Patient holds out hands while physican taps a tablet with Boston Scientific's Vercise Neural Navigator 5 Software showing pre-planned stimulation.

Vercise Genus™ DBS Systems

Vercise™ Neural Navigator 5 Software with Image Guided Programming

Boston Scientific's next innovation in Image Guided Programming

Vercise Neural Navigator 5 (VN5) Software makes it easier and more efficient to personalise your patients’ DBS journey.

Request a demo

Intuitive personalised therapy

VN5 is Boston Scientific’s next innovation in Image Guided Programming. See stimulation to personalize therapy in each patient’s specific anatomy.*

Learn more about Image Guided Programming

Tablet with Vercise Neural Navigator 5 Software showing a split screen of deep brain stimulation lead orientation and programming options.


 

20 minutes

average programming time1

56% reduction

in programming time**

Easy and efficient programming

The new dashboard view shows your patient’s therapy at a glance for efficient decision-making.

Tablet with Vercise Neural Navigator 5 Software showing brain stimulation programming options and IPG information for a specific patient.


 

The most therapy options***

Manage side effects as your patient’s disease progresses with Image Guided Programming.

Graphic showing monopolar stimulation with a deep brain stimulation lead.

Monopolar

Graphic showing bipolar stimulation with a deep brain stimulation lead.

Bipolar

Graphic showing bipolar directional stimulation with a deep brain stimulation lead.

Bipolar Directional (Anodic Block)

Unique stimulation capabilities only available with Boston Scientific

Semi-bipolar and anodic stimulation capabilities are only available with Boston Scientific and are demonstrated to increase side effect threshold2,3 and improve efficacy.4

Two graphics showing semi-bipolar stimulation; one with a deep brain stimulation lead with +50% under it and the other with IPG with +50% under it.

Semi-Bipolar

Anode divided between the IPG and the Lead

Two graphics showinganodic stimulation; one with a deep brain stimulation lead and the other with IPG.

Anodic

100% Anode on the Lead, 100% Cathode on the IPG


 

Stim-on Steering

Stim-on Steering enables simple and accurate assessment of stimulation along the entire electrode.


 

Pre-plan personalised therapy

Pre-plan personalised therapy with Guide XT to make your time with the patient even more efficient.

Tablet showing Vercise Neural Navigator 5 Software with Guide XT for pre-planning therapy based on patient's specific anatomy.

Pre-plan in Guide XT based on patient specific anatomy.

Tablet with Vercise Neural Navigator 5 Software showing a pre-planned stimulation option.

Load pre-planned stimulation when the patient is in the room.

Tablet with Vercise Neural Navigator 5 Software showing a split screen of deep brain stimulation lead orientation and patient-specific program.

Automatically ramp amplitude as you clinically assess the patient.

Stay up to date

Receive emails about the latest DBS advances, clinical data and product news.

Sign up for the latest DBS insights

Connect with us on social media

Hear DBS insights and announcements as they happen.

Follow us on LinkedIn
Follow us on Twitter

If you are a patient looking for more information on DBS, click here for information for patients.

 

*STIMVIEW™ XT Technology is a visual representation of the estimated stimulation field.

**Image Guided programming in PD patients enables a reduction in programming time compared with standard clinical based programming (p=39). 
***Information for competitive devices excerpted from literature published by Medtronic (M982261A015 Rev A, M017563C002 Rev A, M939241A051 Rev A, M927170A073 Rev A, M017562C002 Rev A) and Abbott (ARTEN600150429 - B, ARTEN600102238 - A) Schüpbach, Michael & Chabardes, Stephan & Matthies, Cordula & Pollo, Claudio & Steigerwald, Frank & Timmermann, Lars & Vandewalle, Veerle & Volkmann, Jens & Schuurman, P.. (2017). Directional leads for deep brain stimulation: Opportunities and challenges. Movement Disorders. 32. 10.1002/mds.27096.

REFERENCE:
 1. Lange F, et al. (2021). Reduced Programming Time and Strong Symptom Control Even in Chronic Course Through Imaging-Based DBS Programming. Front. Neurol. 12:785529.doi: 10.3389/fneur.2021.785529 n=10
2. Steffen, J. K., Reker, P., Mennicken, F. K., Dembek, T. A., Dafsari, H. S., Fink, G. R., Visser-Vandewalle, V., & Barbe, M. T. (2020). Bipolar Directional Deep Brain Stimulation in Essential and Parkinsonian Tremor. Neuromodulation: Technology at the Neural Interface, 23(4), 543–549. DOI: 10.1111/ner.13109
3. Reker, P., Dembek, T. A., Becker, J., Visser-Vandewalle, V., & Timmermann, L. (2016). Directional deep brain stimulation: A case of avoiding dysarthria with bipolar directional current steering. Parkinsonism & Related Disorders, 31, 156-158. https://doi.org/10.1016/j.parkreldis.2016.08.007
4. Kirsch, A. D., Hassin-Baer, S., Matthies, C., Volkmann, J., & Steigerwald, F. (2018). Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects. Parkinsonism & Related Disorders, 55, 61-67. https://doi.org/10.1016/j.parkreldis.2018.05.015

Results from different clinical investigations are not directly comparable. Information provided for educational purposes only.

Caution: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.